drugset / Trial / NCT02240589
Memantine for Neuroprotection and Cognitive Enhancement Following Traumatic Brain Injury
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if memantine can improve cognitive and neuropsychiatric outcomes after severe traumatic brain injury.
Timeline
- Start
- 2014-12
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Memantine | Unknown | 10 mg | — |